Atrial Fibrillation Trials in st. john's, canada
Conditions / Atrial Fibrillation / st. john's, canada
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01026090 | Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA) | TERMINATED | PHASE4 |
| NCT01830543 | A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention | COMPLETED | PHASE3 |
| NCT05643573 | A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke | TERMINATED | PHASE3 |
| NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT03505801 | Confirm Rx Insertable Cardiac Monitor SMART Registry | ACTIVE_NOT_RECRUITING | — |
| NCT00781391 | Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00070655 | Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS) | COMPLETED | PHASE3 |
| NCT01674647 | Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion | COMPLETED | PHASE3 |
| NCT01468701 | GLORIA-AF Registry Program - Second and Third Phases | COMPLETED | — |
| NCT00412984 | Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation | COMPLETED | PHASE3 |